Edition:
United States

Robin Respaut

RPT-FOCUS-As China builds biotech sector, cash floods U.S. startups

Sep 24 2018

SAN FRANCISCO/HONG KONG, Sept 24 For three whirlwind days in June, U.S. scientist Zhi Hong went shopping at the Boston Bio Conference to find drugs to fill the pipeline of his two-week-old drug company.

As China builds biotech sector, cash floods U.S. startups

Sep 24 2018

SAN FRANCISCO/HONG KONG For three whirlwind days in June, U.S. scientist Zhi Hong went shopping at the Boston Bio Conference to find drugs to fill the pipeline of his two-week-old drug company.

Millions of Americans still trapped in debt-logged homes ten years after crisis

Sep 14 2018

EAST STROUDSBURG, Pa., 2018 School bus driver Michael Payne was renting an apartment on the 30th floor of a New York City high-rise, where the landlord's idea of fixing broken windows was to cover them with boards. | Video

RPT-INSIGHT-Millions of Americans still trapped in debt-logged homes ten years after crisis

Sep 14 2018

EAST STROUDSBURG, Pa., Sept 14, 2018 School bus driver Michael Payne was renting an apartment on the 30th floor of a New York City high-rise, where the landlord's idea of fixing broken windows was to cover them with boards.

Chinese biotech valuations likely hit as trailblazer's Hong Kong shares sink

Aug 28 2018

HONG KONG/SAN FRANCISCO Biotech startups can expect more measured valuations should they list in Hong Kong, investors and bankers said, after shares of the first such firm to take advantage of rules allowing listings from pre-profit biotechs dropped 44 percent in the first month.

Amicus Therapeutics receives U.S. approval for Fabry disease drug

Aug 10 2018

U.S. health regulators on Friday approved Amicus Therapeutics' Galafold, the first oral therapy to treat Fabry disease, a rare, sometimes fatal condition in which accumulation of fat damages several organs.

Amicus Therapeutics receives U.S. approval for Fabry disease drug

Aug 10 2018

Aug 10 U.S. health regulators on Friday approved Amicus Therapeutics' Galafold, the first oral therapy to treat Fabry disease, a rare, sometimes fatal condition in which accumulation of fat damages several organs.

Amgen profit beats Street view, will not raise prices again in 2018

Jul 26 2018

Amgen Inc on Thursday reported a better-than-expected second quarter profit and raised its full-year earnings forecast, and its chief executive pledged not to raise drug prices again this year.

Gilead CEO Milligan, Chairman Martin to step down

Jul 25 2018

Gilead Sciences Inc said on Wednesday that Chief Executive Officer John Milligan and Chairman John Martin will step down as soon as the end of the year, ending a nearly 30-year run at the U.S. biotech company for both men.

CalSTRS opts to engage assault weapon retailers, not immediate divestment

May 09 2018

The California State Teachers' Retirement System decided on Wednesday to publicly engage retailers of military-style assault weapons in the wake of public outcry over mass shootings, as opposed to immediately reducing investments in these companies.

World News